https://www.selleckchem.com/products/mi-503.html
To evaluate the disease burden of age-related macular degeneration (AMD) in terms of disability-adjusted life years (DALY) in China from 1990 to 2019. Prevalence of blindness and vision loss due to AMD and DALY number, rate, and age-standardized rates of AMD were collected from the Global Burden of Disease Study 2019 database. The characters of variables were analyzed between China and its neighboring countries. From 1990 to 2019, the all-age number and rate for AMD prevalence and DALYs increased significantly in China, while the age sta
Aimer
Commentaire
Partagez
